Reactions 1680, p251 - 2 Dec 2017 Sensory neuropathy: case report A 73-year-old man developed sensory neuropathy during treatment with nelarabine. The man, who had a history of relapsing acute lymphoblastic leukaemia, started receiving treatment with IV nelarabine 1500 mg/m on days 1, 3 and 5 every 21 days. Subsequently, he developed a severe sensory neuropathy of his bilateral lower extremities with profound disturbance in the large fiber/ dorsal column function because of nelarabine [duration of treatment to reaction onset not stated]. The authors considered sensory neuropathy to be serious. The treatment with nelarabine was stopped. He started receiving treatment with decitabine. At nine months follow-up, he showed improvement in his peripheral neuropathy. Author comment: "[H]e developed a severe sensory neuropathy . . . attributed to nelarabine". El Chaer F, et al. Durable remission with salvage decitabine and donor lymphocyte infusion (DLI) for relapsed early T-cell precursor ALL. Bone Marrow Transplantation 52: 1583-1584, No. 11, Nov 2017. Available from: URL: http:// doi.org/10.1038/bmt.2017.191 - USA 803285149 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera